UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Inhibition of intestinal cholesterol absorption by ezetimibe in humans

Circulation (New York, N.Y.), 2002-10, Vol.106 (15), p.1943-1948

2002

Volltextzugriff (PDF)

Efficacy and safety of the coadministration of ezetimibe/simvastatin with fenofibrate in patients with mixed hyperlipidemia

The American heart journal, 2007-02, Vol.153 (2), p.335.e1-335.e8

2007

Volltextzugriff (PDF)

Bayesian Optimal Designs for Phase I Clinical Trials

Biometrics, 2003-09, Vol.59 (3), p.591-600

2003

Volltextzugriff (PDF)

VAP II analysis of lipoprotein subclasses in mixed hyperlipidemic patients on treatment with ezetimibe/simvastatin and fenofibrate

Journal of lipid research, 2008-12, Vol.49 (12), p.2641-2647

2008

Volltextzugriff (PDF)

Effects of a niacin receptor partial agonist, MK-0354, on plasma free fatty acids, lipids, and cutaneous flushing in humans

Journal of clinical lipidology, 2008-10, Vol.2 (5), p.375-383

2008

Volltextzugriff (PDF)

Discussion on "Bayesian Enrichment Strategies for Randomized Discontinuation Trails"

Biometrics, 2012-03, Vol.68 (1), p.217-219

Perevozskaya, Inna

2012

Volltextzugriff (PDF)

Discussion: “Bayesian enrichment strategies for randomized discontinuation trials”

Biometrics, 2012-03, Vol.68 (1), p.217-8; discussion 224-5

Perevozskaya, Inna

2012

Volltextzugriff (PDF)

Discussions

Biometrics, 2012-03, Vol.68 (1), p.217-218

Perevozskaya, Inna

2012

Volltextzugriff (PDF)

A Simulation Study to Compare New Adaptive Dose-Ranging Designs

Statistics in biopharmaceutical research, 2010-11, Vol.2 (4), p.487-512

2010

Volltextzugriff (PDF)

Adaptive Dose-Response Studies

Drug information journal, 2006-10, Vol.40 (4), p.451-461

2006

Volltextzugriff (PDF)

Inhibition of intestinal cholesterol absorption by ezetimibe in humans

Atherosclerosis. Supplements, 2002-10, Vol.3 (2), p.213

2002

Volltextzugriff (PDF)

Effects of simvastatin on the lipid profile and attainment of low-density lipoprotein cholesterol goals when added to thiazolidinedione therapy in patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, placebo-controlled trial

Clinical therapeutics, 2004, Vol.26 (3), p.379-389

2004

Volltextzugriff (PDF)

Planning and Executing Response-Adaptive Learn-Phase Clinical Trials: 1. The Process

Drug information journal, 2009-11, Vol.43 (6), p.713-723

2009

Volltextzugriff (PDF)

Planning and Executing Response-Adaptive Learn-Phase Clinical Trials: 2. Case Studies

Drug information journal, 2009-11, Vol.43 (6), p.725-734

2009

Volltextzugriff (PDF)

Predicting the COVID-19 Pandemic Impact on Clinical Trial Recruitment

Statistics in biopharmaceutical research, 2022-01, Vol.14 (1), p.67-79

2022

Volltextzugriff (PDF)

Simulation Practices for Adaptive Trial Designs in Drug and Device Development

Statistics in biopharmaceutical research, 2019-10, Vol.11 (4), p.325-335

2019

Volltextzugriff (PDF)

Improved prediction intervals in heteroscedastic mixed-effects models

Statistics & probability letters, 2016-07, Vol.114, p.48-53

2016

Volltextzugriff (PDF)

Efficacy and safety of the coadministration of ezetimibe with fenofibrate in patients with mixed hyperlipidaemia

European heart journal, 2005-05, Vol.26 (9), p.897-905

2005

Volltextzugriff (PDF)

Comparing oncology clinical programs by use of innovative designs and expected net present value optimization: Which adaptive approach leads to the best result?

Journal of biopharmaceutical statistics, 2017-01, Vol.27 (3), p.457-476

2017

Volltextzugriff (PDF)

Adaptive dose finding based on t-statistic for dose-response trials

Statistics in medicine, 2008-05, Vol.27 (10), p.1581-1592

2008

Volltextzugriff (PDF)

Development of Interactive Software for Bayesian Optimal Phase 1 Clinical Trial Design

Drug information journal, 2005-01, Vol.39 (1), p.89-98

2005

Volltextzugriff (PDF)

Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia

Metabolism, clinical and experimental, 2008-06, Vol.57 (6), p.796-801

2008

Volltextzugriff (PDF)

Simple Randomization

Methods and Applications of Statistics in Clinical Trials, 2014, p.841-849

2014

Volltextzugriff (PDF)

Improving Oncology Clinical Programs by Use of Innovative Designs and Comparing Them via Simulations

Therapeutic innovation & regulatory science, 2013-09, Vol.47 (5), p.602-612

2013

Volltextzugriff (PDF)

Advances in Statistical Approaches to Oncology Drug Development

Therapeutic innovation & regulatory science, 2014-01, Vol.48 (1), p.81-89

2014

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(36)

Publikationsform

Sprache

Englisch
(36)

Erscheinungsjahr

n.n

Thema

Science & Technology
(24)
Life Sciences & Biomedicine
(22)
Mathematics
(11)
Physical Sciences
(11)
Statistics & Probability
(11)
Humans
(10)
Pharmacology & Pharmacy
(10)
Clinical Trials
(7)
Design
(7)
Mathematical & Computational Biology
(7)
Middle Aged
(6)
Adult
(5)
Double-Blind Method
(5)
Ezetimibe
(5)
Male
(5)
Pharmacotherapy
(5)
Aged
(4)
Azetidines - Administration & Dosage
(4)
Biological And Medical Sciences
(4)
Drug Safety And Pharmacovigilance
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Inhibition of intestinal cholesterol absorption by ezetimibe in humans

Efficacy and safety of the coadministration of ezetimibe/simvastatin with fenofibrate in patients with mixed hyperlipidemia

Bayesian Optimal Designs for Phase I Clinical Trials

VAP II analysis of lipoprotein subclasses in mixed hyperlipidemic patients on treatment with ezetimibe/simvastatin and fenofibrate

Effects of a niacin receptor partial agonist, MK-0354, on plasma free fatty acids, lipids, and cutaneous flushing in humans

Discussion on "Bayesian Enrichment Strategies for Randomized Discontinuation Trails"

Discussion: “Bayesian enrichment strategies for randomized discontinuation trials”

Discussions

A Simulation Study to Compare New Adaptive Dose-Ranging Designs

Adaptive Dose-Response Studies

Inhibition of intestinal cholesterol absorption by ezetimibe in humans

Effects of simvastatin on the lipid profile and attainment of low-density lipoprotein cholesterol goals when added to thiazolidinedione therapy in patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, placebo-controlled trial

Planning and Executing Response-Adaptive Learn-Phase Clinical Trials: 1. The Process

Planning and Executing Response-Adaptive Learn-Phase Clinical Trials: 2. Case Studies

Predicting the COVID-19 Pandemic Impact on Clinical Trial Recruitment

Simulation Practices for Adaptive Trial Designs in Drug and Device Development

Improved prediction intervals in heteroscedastic mixed-effects models

Efficacy and safety of the coadministration of ezetimibe with fenofibrate in patients with mixed hyperlipidaemia

Comparing oncology clinical programs by use of innovative designs and expected net present value optimization: Which adaptive approach leads to the best result?

Adaptive dose finding based on t-statistic for dose-response trials

Development of Interactive Software for Bayesian Optimal Phase 1 Clinical Trial Design

Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia

Simple Randomization

Improving Oncology Clinical Programs by Use of Innovative Designs and Comparing Them via Simulations

Advances in Statistical Approaches to Oncology Drug Development

Suchergebnisse filtern